Red Glead is exhibiting at Discovery on Target in Boston, US
Red Glead is exhibiting at Discovery on Target (DOT) Boston, 25-28th of September (booth #201). The event covers advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutics.
Kirill Popov and Johan Evenäs will showcase fragment-based and computational chemistry hit finding approaches. Stop by to find out how Red Glead Discovery’s integrated drug discovery platform and expertise can help advancing your project.
We look forward to meeting you to further discuss how we may support your project.
We have considerable experience of a variety of hit finding approaches including computational methods, structure-based design, innovative follower workflows, and fragment-based lead discovery including the WAC™ screening technology. Our established collaboration with SARomics Biostructures is a cornerstone for efficient structure-based design throughout the drug discovery phases.
Our laboratory capabilities in medicinal, organic, and analytical chemistry are focused on small molecules and peptides. These are complemented with in vitro biology and ADME profiling. Altogether, this enables us to drive your project from chemical starting point to candidate compound in a timely and efficient fashion.
Are you interested to explore how we can help advance your drug discovery projects? Reach out to us or read more about our services on RedGlead Discovery » Services